These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity. Tellier E; Widemann A; Cauchois R; Faccini J; Lagarde M; Brun M; Robert P; Robert S; Bachelier R; Poullin P; Roose E; Vanhoorelbeke K; Coppo P; Dignat-George F; Kaplanski G Haematologica; 2023 Apr; 108(4):1127-1140. PubMed ID: 36453103 [TBL] [Abstract][Full Text] [Related]
30. Platelets: thrombotic thrombocytopenic purpura. George JN; Sadler JE; Lämmle B Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430 [TBL] [Abstract][Full Text] [Related]
31. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura. Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235 [TBL] [Abstract][Full Text] [Related]
32. Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura. Mancini I; Ricaño-Ponce I; Pappalardo E; Cairo A; Gorski MM; Casoli G; Ferrari B; Alberti M; Mikovic D; Noris M; Wijmenga C; Peyvandi F; J Thromb Haemost; 2016 Dec; 14(12):2356-2367. PubMed ID: 27762046 [TBL] [Abstract][Full Text] [Related]
33. Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura. Picod A; Coppo P Expert Rev Hematol; 2019 Jun; 12(6):461-471. PubMed ID: 31092093 [No Abstract] [Full Text] [Related]